Think Pink Rocks

Killer coating destroys bacteria and fungi on contact

admin — Fri, 11 May 2012 20:16:16 +0000

Better than antibiotics, it is being used in contact lenses to prevent infections and biomedical products are the next stage

Viewpoints: Two views on how to fight obesity; Tough choices for big business on health costs

admin — Fri, 11 May 2012 20:14:16 +0000

Forgive us if we don’t cheer at the prospect of adding 32 million to the total number of Americans who are dozens of pounds too heavy, a count that stood in 2010 at 78 million.

See the article here:
Viewpoints: Two views on how to fight obesity; Tough choices for big business on health costs

Positive results from PROLOR Biotech’s hGH-CTP Phase II trial for growth hormone deficiency

admin — Mon, 07 May 2012 20:29:55 +0000

PROLOR Biotech, Inc. today reported top-line results from a Phase II four-month treatment extension study of hGH-CTP, its long-acting version of human growth hormone, in growth hormone deficient adults.

View article:
Positive results from PROLOR Biotech’s hGH-CTP Phase II trial for growth hormone deficiency

Obama, Romney and their supporters debate government role in health care

admin — Mon, 07 May 2012 18:22:52 +0000

[Bill] Clinton defended the Affordable Care Act that Obama signed into law in 2010, which is now the subject of debate among U.S.

View the original here:
Obama, Romney and their supporters debate government role in health care

Galleon GAL-021 safe and well-tolerated in Phase I respiratory depression clinical study

admin — Mon, 07 May 2012 16:30:30 +0000

Galleon Pharmaceuticals, a leader in the development of novel medicines to treat breathing disorders, today announced that its investigational drug GAL-021 appeared to be safe and well-tolerated and demonstrated dose-proportional pharmacokinetic effects on respiration in a Phase I clinical study of 30 healthy adults.

View article:
Galleon GAL-021 safe and well-tolerated in Phase I respiratory depression clinical study

Data from Idera IMO-8400 preclinical studies for SLE and psoriasis presented at AAI meeting

admin — Mon, 07 May 2012 15:30:27 +0000

Idera Pharmaceuticals, Inc.

More:
Data from Idera IMO-8400 preclinical studies for SLE and psoriasis presented at AAI meeting

IOM releases summary of workshop on drug-resistant TB in India

Fri, 27 Apr 2012 21:09:52 +0000

The Institute of Medicine (IOM) on Friday released a summary of a joint workshop by the Institute of Medicine, the Indian National Science Academy, and the Indian Council of Medical Research, titled, “Facing the Reality of Drug-Resistant Tuberculosis: Challenges and Potential Solutions in India.”

Originally posted here:
IOM releases summary of workshop on drug-resistant TB in India

Binge drinking may slow recovery and increase medical costs for survivors of burn injuries

Fri, 27 Apr 2012 21:02:37 +0000

A Loyola University Medical Center study has found that binge drinking may slow recovery and increase medical costs for survivors of burn injuries.

Visit link:
Binge drinking may slow recovery and increase medical costs for survivors of burn injuries

Lack of awareness, cultural beliefs, transport challenges leading to high number of maternal deaths in Ethiopia, officials say

Fri, 27 Apr 2012 21:01:16 +0000

“A lack of awareness of the importance of skilled hospital deliveries in Ethiopia, cultural beliefs, and transport challenges in rural areas are causing a high number of deaths during childbirth,” officials say, according to IRIN.

See original article:
Lack of awareness, cultural beliefs, transport challenges leading to high number of maternal deaths in Ethiopia, officials say

Single biennial HIV prevention conference planned

Sat, 21 Apr 2012 13:54:27 +0000

This year’s International Microbicides Conference, held this week in Sydney, “will be the last of its kind” because “from 2014 onwards, it is planned, a single biennial conference on all aspects of HIV prevention will be held,” according to an aidsmap news story.